Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation
Radiofrequency ablation (RFA) is an important strategy for treatment of advanced hepatocellular carcinoma (HCC). However, the prognostic indicators of RFA therapy are not known, and there are few strategies for RFA sensitization. The transcription factor sterol regulatory element binding protein 1 (...
Guardado en:
Autores principales: | Xiao-zheng Zou, Jun-feng Hao, Xiu-hua Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c3b72a56c4af459e972967d3937455c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China:
a comprehensive meta-analysis
por: Zhijun Li, et al.
Publicado: (2021) -
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
por: Bin Chai, et al.
Publicado: (2021) -
Correlation and agreement between superb micro-vascular imaging and contrast-enhanced ultrasound for assessing radiofrequency ablation treatment of thyroid nodules: a preliminary study
por: Yu Lan, et al.
Publicado: (2021) -
Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis
por: Xiaofei Wang, et al.
Publicado: (2021) -
Comparison between subtraction and dynamic MRI in assessing treatment response following radiofrequency ablation in patients with hepatocellular carcinoma
por: Ahmed Elshenawy Gabr, et al.
Publicado: (2021)